Found 3 articles for: "obesity"
GLP-1 Receptor Agonists in Overweight and Obese Patients With Hidradenitis Suppurativa
February 2026 | Volume 25 | Issue 2 | Features | 178 | Copyright © February 2026
GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A Novel Therapeutic Approach for Hidradenitis Suppurativa and Its Comorbidities
December 2025 | Volume 24 | Issue 12 | Original Article | 1174 | Copyright © December 2025
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder associated with many comorbidities, including obesity, diabetes, cardiovascular risk factors, me...
Read MoreAn Open-Label, Single-Center Proof of Concept Study Evaluating the Efficacy and Safety of Tirzepatide for Moderate to Severe Hidradenitis Suppurativa
December 2025 | Volume 24 | Issue 12 | Original Article | 1246 | Copyright © December 2025
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory disease associated with obesity and metabolic dysregulation. Current therapies yield variable benefits and do ...
Read More
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.